Business
Ironwood Pharmaceuticals to Present at the 29th Annual Credit Suisse Healthcare Conference
BOSTON--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will participate in a virtual fireside chat at the 29th Annual Credit Suisse
About this update from Ironwood Pharmaceuticals, Inc.
[{"type":"text","content":" BOSTON--(BUSINESS WIRE)--\nIronwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will participate in a virtual fireside chat at the 29th Annual Credit Suisse Healthcare Conference on Wednesday, November 11, 2020 at 3:30 p.m. Eastern Time.\n\nA live webcast of Ironwood’s fireside chat will be accessible through the Investors section of the company’s website at www.ironwoodpharma.com. To access the webcast, please log on to the Ironwood website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Ironwood’s website for 14 days following the conference.\n\nAbout Ironwood Pharmaceuticals\n\nIronwood Pharmaceuticals (Nasdaq: IRWD) is a GI-focused healthcare company dedicated to creating medicines that make a difference for patients living with GI diseases. We discovered, developed and are commercializing linaclotide, the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC).\n\nIronwood was founded in 1998 and is headquartered in Boston, Mass. For more information, please visit our website at www.ironwoodpharma.com or www.twitter.com/ironwoodpharma; information that may be important to investors will be routinely posted in both these locations.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20201106005499/en/\n\nInvestor and Media Relations\nMeredith Kaya, 617-374-5082\nVice President, Strategy, Investor Relations and Corporate Communications\[email protected]\n\nSource: Ironwood Pharmaceuticals, Inc.","length":3765,"tagName":"div"}]